Abbott’s Amplatzer Piccolo Occluder Device Repairs Infant with an Opening in the Heart at St. Joseph’s Children’s Hospital in West Central Florida, 1st in the Region

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

December 4, 2020

Abbott’s Amplatzer Piccolo Occluder Device is available at St. Joseph’s Hospital in West Central Florida.

The hospital notes infant Samantha Castellanos-Santana was delivered at 30 weeks gestation and was born with an opening in her heart, a condition known as patent ductus arteriosus. On Nov. 25, 2020, Samantha became the first patient in West Central Florida to have this type of heart defect repaired using Abbott’s Amplatzer Piccolo Occluder, a device smaller than a pea. St. Joseph’s Children’s Hospital is the region’s first hospital to use the Piccolo device, the only device U.S. FDA approved to close PDAs in premature babies.

“The Piccolo Occluder greatly increases our ability to close PDAs in the tiniest, most medically fragile babies, offering better options for patients who need corrective treatment and are high risk to undergo heart surgery,” said Dr. Jeremy Ringewald, a pediatric interventional cardiologist and the medical director of the Cardiac Catheterization Laboratory at St. Joseph’s Children’s Hospital in Tampa.

The most common congenital heart defect occurring in premature babies, PDA occurs when a blood vessel in the fetal heart that is supposed to close after birth – the ductus arteriosus – remains open. According to Dr. Ringewald, this opening is present in normally developing infants and typically closes spontaneously shortly after birth. Often in babies born prematurely, the PDA fails to close. This makes it difficult for babies to breathe normally due to increased blood flow to the lungs.

During Samantha’s procedure, Dr. Ringewald inserted a tiny catheter tube into a vein in the leg and guided the catheter into the PDA. He then advanced the self-expanding, wire mesh device through the catheter to spring open in the PDA, sealing it closed immediately.

“Since the device is implanted through a minimally invasive procedure, many of the premature babies who are critically ill in the neonatal intensive care unit can be weaned from the breathing machine soon after the procedure,” said Dr. Ringewald.

He adds that since patients do not outgrow the device after implantation, there is no need for additional procedures related to the PDA. Once the device is placed to seal the opening, it becomes part of the baby’s tissue, and is sealed for life.

St. Joseph’s Children’s Hospital is home to the Tampa Bay area’s only comprehensive congenital heart disease program, and its pediatric heart physicians perform hundreds of cardiac procedures each year to treat congenital and acquired heart conditions in children of any age, including newborns. A partnership between St. Joseph’s Children’s Hospital and the Children’s Hospital of Pittsburgh of UPMC provides families across Florida with unprecedented access to the highest level of pediatric heart care available. Together, they provide highly specialized cardiovascular care for patients ranging from babies in the womb to adults with congenital heart disease.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.